Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3522656019 | Product containing erythromycin ethylsuccinate and sulfafurazole acetyl (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3522659014 | Product containing erythromycin ethylsuccinate and sulfisoxazole acetyl | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3522660016 | Product containing erythromycin ethylsuccinate and sulfafurazole acetyl | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3695107016 | Erythromycin ethyl succinate and sulfafurazole acetyl product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3695108014 | Erythromycin ethylsuccinate and sulfisoxazole acetyl product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3667801000005119 | erythromycinethylsuccinat + sulfisoxazolacetyl | da | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Danish module (core metadata concept) |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
erythromycinethylsuccinat 200 mg + sulfisoxazolacetyl 600 mg oral suspension | Is a | False | erythromycinethylsuccinat + sulfisoxazolacetyl | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set